Indeed, nuclear GAPDH was observed in postmortem brain tissues of AD [90,139] and PD [140] patients, and HD transgenic mice [141], indicating that nuclear targeting of the enzyme may be a common pathological feature in different neurodegenerative pathologies. The gene discussed is GAPDH; the disease is Parkinson disease.